Stellate Ganglion Block for Long COVID Symptom Management: A Case Report

Authors

Mashfee H Khan
Kennedy P Kirkpatrick
Yi Deng
Krishna B Shah

Publication Date

12-1-2022

Journal

Cureus

DOI

10.7759/cureus.32295

PMID

36628048

PMCID

PMC9822527

PubMedCentral® Posted Date

12-7-2022

PubMedCentral® Full Text Version

Post-print

Published Open-Access

yes

Keywords

long-covid, stellate ganglion block, chronic fatigue, stellate ganglion, covid 19

Abstract

Stellate ganglion block (SGB) is gaining increasing acceptance as a treatment modality for various medical conditions. It works by blocking neuronal transmissions which in turn alleviates sympathetically-driven disease processes. Many of the prolonged sequelae of long COVID are thought to be mediated by dysregulation of the autonomic nervous system, and SGB is being investigated as a potential option for symptomatic management of long COVID. This case report demonstrates the efficacy of SGB in a previously healthy patient for the management of long COVID symptoms including fatigue, post-exertional malaise, shortness of breath, and gastrointestinal symptoms.